Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating Functions
Giovannino Silvestri(University of Maryland, Baltimore), Danilo Perrotti(Cancer Genetics (United States)), Alistair Reid(Hammersmith Hospital), Christopher J. Walker(Ohio University), Peter Hokland(Aarhus University), Gabriel Pineda(Henry M. Jackson Foundation), Justin J. Ellis(University of Indianapolis), Garrett Fitzgerald(University of Maryland, Baltimore), Jianfei Qi(University of Maryland, Baltimore), Martin Guimond(The Ohio State University), Catriona Jamieson(La Jolla Alcohol Research), Jason G. Harb(AbbVie (United States)), Xiaoxuan Fan(University of Maryland, Baltimore), Carlo Gambacorti‐Passerini(Azienda Ospedaliera San Gerardo), Paolo Vigneri(Humanitas University), Bruno Calabretta(Sidney Kimmel Cancer Center), Lorenzo Stramucci(University of Maryland, Baltimore), Philippa C. May(Hammersmith Hospital), Maria R. Baer(University of Maryland, Baltimore), Rossana Trotta(University of Maryland, Baltimore), Denis‐Claude Roy(Hôpital Maisonneuve-Rosemont), Ramiro Garzon(Unknown), Moutuaata M. Moutuou(Hôpital Maisonneuve-Rosemont), Guido Marcucci(City of Hope), Paolo Neviani(Children's Hospital of Los Angeles), Francesco Dazzi(King's College London), Kateřina Machová Poláková(Institute of Haematology and Blood Transfusion), Ying Zou(Lanzhou University), Jane F. Apperley(Hammersmith Hospital), Shuzhen Wang(China Pharmaceutical University), Fabio Stagno, Dragana Milojković(Imperial College Healthcare NHS Trust), Christopher Harman(University of Maryland, Baltimore), Ann‐Kathrin Eisfeld, Klára Šrůtová(Institute of Haematology and Blood Transfusion), Michael W. Deininger(Versiti Blood Center of Wisconsin), Bin Zhang(Icahn School of Medicine at Mount Sinai), Georgios Nteliopoulos(Hammersmith Hospital)
Cited by 34
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Canadian Implantable Defibrillator Study (CIDS)
|Circulation|2000|1.6k
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k